Since chemotherapy is one of the major treatments for NSCLC patients in a setting of almost certain eventual chemoresistance, we next investigated whether SET overexpression affects the sensitivity of lung cancer cells to chemotherapy. Here, SET is linked to non-small cell lung carcinoma.